Alessio Alfieri

Associate Director, Neurodegeneration @Sudo Biosciences

Cambridgeshire, GB

Neurodegeneration lead in the Translational Pharmacology team, Non-Clinical R&D-Preclinical drug discovery, models of neuroinflammation and neurodegeneration: Alzheimer’s disease, motor-neuron disease (MND) including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS); PK/PD/efficacy relationships and MoA-Matrix team leadership to design and implement the translational strategy supporting key project stage milestones and the company’s pipeline, including setting criteria for go/no-go decision, indication prioritization, regulatory documents-Directing and monitoring external studies (partnering or servicing CROs), from due diligence evaluations to contract signature and reporting-Pipeline expansion, focusing on target biology evaluation and translational and experimental models

Università degli Studi di Napoli Federico II

Doctor of Philosophy - PhD

Università degli Studi di Napoli Federico II

Master of Pharmacy